EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Non‐Melanoma Skin Cancer in Transplant Recipients: A Single‐Centre Retrospective Cohort Study on the Role of Transplant Type, Immunosuppressive Exposure, and Tumor Subtypes

Corrado Zengarini iD, Vittoria Tagnin, Gioia Sorbi, Alba Guglielmo, Michelangelo La Placa, Bianca Maria Piraccini, Alessandro Pileri, Marco Pignatti

Clinical Transplantation · 2026

DOI: 10.1111/ctr.70451 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Clinical Transplantation, 2026. Verfasst von Corrado Zengarini und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy. Hauptthemen laut MEDLINE: Immunosuppressive Agents, Non-Melanoma Skin Neoplasms, Organ Transplantation, Transplant Recipients. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università di Bologna.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Non‐melanoma skin cancer (NMSC) is a frequent long‐term complication in transplant recipients, mainly due to chronic immunosuppression. Its incidence varies by transplant type and regimen, but existing evidence is often fragmented.

Objective

To assess long‐term incidence and risk factors for NMSC, comparing transplant types, immunosuppressive regimens, and tumor subtypes.

Methods

This retrospective cohort comprised 901 transplant recipients (1975–2024) who were under long‐term dermatologic follow‐up. Data on transplant type, immunosuppressive regimen/duration, and tumor subtype were analyzed. NMSC‐free survival was evaluated with Kaplan–Meier curves; Cox regression assessed predictors.

Results

Among 901 transplant recipients, 191 (21.2%) developed at least one NMSC during long‐term follow‐up. Crude incidence rates ranged between 1.88 and 2.68 per 100 person‐years across immunosuppressive drug classes and agents. In multivariable Cox models, older age at first transplant was independently associated with higher NMSC risk (HR 1.07 per year, 95% CI 1.06–1.09, p < 0.001). Sex, transplant group, and ever‐use of individual immunosuppressive agents were not significantly associated with NMSC risk after adjustment.

Conclusion

In this long‐term cohort, NMSC risk increased with age at first transplant, whereas transplant organ and ever‐use of major immunosuppressive agents were not independently associated in adjusted models. Over an extended follow‐up, NMSC accumulated steadily, with crude incidence rates around 1.88–2.68 cases per 100 person‐years across immunosuppressive classes and agents, underscoring the cumulative nature of skin cancer risk under chronic immunosuppression. Our results reinforce the need for sustained, long‐term dermatologic surveillance, particularly in older patients undergoing transplantation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunosuppressive AgentsNon-Melanoma Skin NeoplasmsOrgan TransplantationTransplant RecipientsSkin NeoplasmsPostoperative ComplicationsBasal Cell CarcinomaHumansFemaleRetrospective StudiesMaleFollow-Up StudiesIncidenceMiddle AgedRisk FactorsPrognosisAdultSurvival RateAged

Stichwörter der Autor:innen

BCCNMSCSCCimmunosuppressionlong‐term follow‐upmalignanciesorgan transplantationskin cancer screeningsurvival analysistransplant recipients

Substanzen

Immunosuppressive Agents

Autor:innen und Institutionen

  • Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
  • Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy.
  • Plastic Surgery Unit, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy.
  • Department of Medical Sciences, Section of Dermatology and Infectious Diseases, University of Ferrara, Ferrara, Italy.

ORCID-Profile: Corrado Zengarini

Förderung

  • Università di Bologna

Zitieren

APA

Zengarini, C., Tagnin, V., Sorbi, G., Guglielmo, A., La Placa, M., Piraccini, B. M., Pileri, A., & Pignatti, M. (2026). Non‐Melanoma Skin Cancer in Transplant Recipients: A Single‐Centre Retrospective Cohort Study on the Role of Transplant Type, Immunosuppressive Exposure, and Tumor Subtypes. Clinical Transplantation. https://doi.org/10.1111/ctr.70451

Vancouver

Zengarini C, Tagnin V, Sorbi G, Guglielmo A, La Placa M, Piraccini BM, et al. Non‐Melanoma Skin Cancer in Transplant Recipients: A Single‐Centre Retrospective Cohort Study on the Role of Transplant Type, Immunosuppressive Exposure, and Tumor Subtypes. Clinical Transplantation. 2026. doi:10.1111/ctr.70451

BibTeX
@article{Zengarini2026,
  author = {Zengarini, Corrado and Tagnin, Vittoria and Sorbi, Gioia and Guglielmo, Alba and La Placa, Michelangelo and Piraccini, Bianca Maria and Pileri, Alessandro and Pignatti, Marco},
  title = {Non‐Melanoma Skin Cancer in Transplant Recipients: A Single‐Centre Retrospective Cohort Study on the Role of Transplant Type, Immunosuppressive Exposure, and Tumor Subtypes},
  journal = {Clinical Transplantation},
  year = {2026},
  doi = {10.1111/ctr.70451}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche